

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | polyketide metabolic process (GO:0030638) | 9.69599642 |
| 2 | doxorubicin metabolic process (GO:0044598) | 9.69599642 |
| 3 | daunorubicin metabolic process (GO:0044597) | 9.69599642 |
| 4 | maintenance of protein location in nucleus (GO:0051457) | 6.57298555 |
| 5 | somite rostral/caudal axis specification (GO:0032525) | 6.20342905 |
| 6 | protein localization to kinetochore (GO:0034501) | 6.16747999 |
| 7 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 6.00360509 |
| 8 | aminoglycoside antibiotic metabolic process (GO:0030647) | 5.99008179 |
| 9 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 5.82279151 |
| 10 | regulation of telomere maintenance via telomerase (GO:0032210) | 5.73164711 |
| 11 | regulation of response to osmotic stress (GO:0047484) | 5.65862681 |
| 12 | negative regulation of epidermis development (GO:0045683) | 5.60922441 |
| 13 | histone H4-K8 acetylation (GO:0043982) | 5.60752514 |
| 14 | histone H4-K5 acetylation (GO:0043981) | 5.60752514 |
| 15 | regulation of MHC class I biosynthetic process (GO:0045343) | 5.49863279 |
| 16 | positive regulation by symbiont of host defense response (GO:0052509) | 5.49151487 |
| 17 | modulation by symbiont of host defense response (GO:0052031) | 5.49151487 |
| 18 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.49151487 |
| 19 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.49151487 |
| 20 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.49151487 |
| 21 | modulation by symbiont of host immune response (GO:0052553) | 5.49151487 |
| 22 | negative regulation of telomerase activity (GO:0051974) | 5.48674820 |
| 23 | negative regulation of cell killing (GO:0031342) | 5.45571393 |
| 24 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.45571393 |
| 25 | muscle organ morphogenesis (GO:0048644) | 5.29199353 |
| 26 | histone H4-K12 acetylation (GO:0043983) | 5.21461638 |
| 27 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 5.14961340 |
| 28 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.11990233 |
| 29 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 5.09799562 |
| 30 | rRNA transcription (GO:0009303) | 4.90225751 |
| 31 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.89299767 |
| 32 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.78031563 |
| 33 | notochord development (GO:0030903) | 4.77834733 |
| 34 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.77253310 |
| 35 | mitotic sister chromatid segregation (GO:0000070) | 4.75666352 |
| 36 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.71955335 |
| 37 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.64296065 |
| 38 | regulation of translation in response to stress (GO:0043555) | 4.63582404 |
| 39 | cytidine deamination (GO:0009972) | 4.62280676 |
| 40 | cytidine metabolic process (GO:0046087) | 4.62280676 |
| 41 | cytidine catabolic process (GO:0006216) | 4.62280676 |
| 42 | protein localization to chromosome, centromeric region (GO:0071459) | 4.58490401 |
| 43 | heterochromatin organization (GO:0070828) | 4.52905613 |
| 44 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 4.44551614 |
| 45 | negative regulation of interleukin-12 production (GO:0032695) | 4.44452326 |
| 46 | detection of other organism (GO:0098543) | 4.43095863 |
| 47 | response to peptidoglycan (GO:0032494) | 4.42314173 |
| 48 | immunoglobulin mediated immune response (GO:0016064) | 4.41125795 |
| 49 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.37133019 |
| 50 | detection of bacterium (GO:0016045) | 4.36075582 |
| 51 | macrophage activation involved in immune response (GO:0002281) | 4.27579309 |
| 52 | interferon-gamma production (GO:0032609) | 4.26092796 |
| 53 | neutrophil activation involved in immune response (GO:0002283) | 4.22751678 |
| 54 | negative regulation of epidermal cell differentiation (GO:0045605) | 4.21935909 |
| 55 | histone H4-K16 acetylation (GO:0043984) | 4.18890066 |
| 56 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 4.15494845 |
| 57 | nuclear pore complex assembly (GO:0051292) | 4.12987548 |
| 58 | hormone catabolic process (GO:0042447) | 4.03649693 |
| 59 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 4.01487340 |
| 60 | negative regulation of telomere maintenance (GO:0032205) | 4.01008904 |
| 61 | response to dietary excess (GO:0002021) | 4.00541778 |
| 62 | regulation of cilium movement (GO:0003352) | 4.00280214 |
| 63 | rRNA methylation (GO:0031167) | 3.97188178 |
| 64 | sister chromatid segregation (GO:0000819) | 3.96235839 |
| 65 | proline transport (GO:0015824) | 3.94436873 |
| 66 | chromatin assembly (GO:0031497) | 3.93059322 |
| 67 | cellular response to type I interferon (GO:0071357) | 3.85351008 |
| 68 | type I interferon signaling pathway (GO:0060337) | 3.85351008 |
| 69 | cellular response to interleukin-15 (GO:0071350) | 3.84869577 |
| 70 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.82314703 |
| 71 | response to host immune response (GO:0052572) | 3.82314703 |
| 72 | response to type I interferon (GO:0034340) | 3.79673162 |
| 73 | mitochondrion distribution (GO:0048311) | 3.78557615 |
| 74 | respiratory burst (GO:0045730) | 3.76478586 |
| 75 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.76279245 |
| 76 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.75815395 |
| 77 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.75815395 |
| 78 | pre-miRNA processing (GO:0031054) | 3.75515274 |
| 79 | maintenance of protein localization in organelle (GO:0072595) | 3.74612603 |
| 80 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771) | 3.74562688 |
| 81 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 3.73469009 |
| 82 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.71014752 |
| 83 | positive regulation of protein deacetylation (GO:0090312) | 3.68950003 |
| 84 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.68065372 |
| 85 | primitive streak formation (GO:0090009) | 3.66424898 |
| 86 | nucleoside transmembrane transport (GO:1901642) | 3.65990221 |
| 87 | detection of external biotic stimulus (GO:0098581) | 3.65211237 |
| 88 | DNA replication checkpoint (GO:0000076) | 3.62657521 |
| 89 | rRNA modification (GO:0000154) | 3.60418871 |
| 90 | phenol-containing compound catabolic process (GO:0019336) | 3.60404387 |
| 91 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.59853179 |
| 92 | response to interleukin-15 (GO:0070672) | 3.58696758 |
| 93 | positive regulation of histone deacetylation (GO:0031065) | 3.57551297 |
| 94 | NIK/NF-kappaB signaling (GO:0038061) | 3.57527127 |
| 95 | leukocyte aggregation (GO:0070486) | 3.57085142 |
| 96 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.55294421 |
| 97 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 3.54272315 |
| 98 | positive regulation of interferon-alpha production (GO:0032727) | 3.52494277 |
| 99 | neutrophil activation (GO:0042119) | 3.52280882 |
| 100 | microtubule severing (GO:0051013) | 3.51520311 |
| 101 | tachykinin receptor signaling pathway (GO:0007217) | 3.50909528 |
| 102 | bone trabecula formation (GO:0060346) | 3.50539599 |
| 103 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.50515514 |
| 104 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.50515514 |
| 105 | T cell migration (GO:0072678) | 3.49654823 |
| 106 | mitotic chromosome condensation (GO:0007076) | 3.47616509 |
| 107 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.46690020 |
| 108 | regulation of interferon-alpha production (GO:0032647) | 3.45874988 |
| 109 | retinoic acid receptor signaling pathway (GO:0048384) | 3.45776505 |
| 110 | B cell mediated immunity (GO:0019724) | 3.45385354 |
| 111 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 3.45181507 |
| 112 | cellular extravasation (GO:0045123) | 3.41892357 |
| 113 | nuclear pore organization (GO:0006999) | 3.40106257 |
| 114 | regulation of gamma-delta T cell activation (GO:0046643) | 3.39827362 |
| 115 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.39473553 |
| 116 | response to muramyl dipeptide (GO:0032495) | 3.38082326 |
| 117 | granulocyte activation (GO:0036230) | 3.36994056 |
| 118 | B cell receptor signaling pathway (GO:0050853) | 3.36177027 |
| 119 | negative regulation of T cell mediated immunity (GO:0002710) | 3.33389140 |
| 120 | response to host (GO:0075136) | 3.32458295 |
| 121 | response to host defenses (GO:0052200) | 3.32458295 |
| 122 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.32458295 |
| 123 | detection of biotic stimulus (GO:0009595) | 3.31311036 |
| 124 | regulation of hippo signaling (GO:0035330) | 3.29977386 |
| 125 | detection of molecule of bacterial origin (GO:0032490) | 3.29947477 |
| 126 | mRNA stabilization (GO:0048255) | 3.29568139 |
| 127 | RNA stabilization (GO:0043489) | 3.29568139 |
| 128 | positive regulation of mast cell activation (GO:0033005) | 3.29084765 |
| 129 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 3.27548418 |
| 130 | detection of temperature stimulus (GO:0016048) | 3.27234022 |
| 131 | myeloid cell activation involved in immune response (GO:0002275) | 3.25464193 |
| 132 | regulation of mast cell degranulation (GO:0043304) | 3.25252592 |
| 133 | microglial cell activation (GO:0001774) | 3.24481210 |
| 134 | defense response to protozoan (GO:0042832) | 3.24218195 |
| 135 | negative regulation of viral release from host cell (GO:1902187) | 3.23163546 |
| 136 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.19632843 |
| 137 | regulation of telomerase activity (GO:0051972) | 3.19422998 |
| 138 | regulation of B cell differentiation (GO:0045577) | 3.17760916 |
| 139 | protein polyglutamylation (GO:0018095) | 3.16466290 |
| 140 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.15633179 |
| 141 | hypotonic response (GO:0006971) | 3.15437842 |
| 142 | coenzyme catabolic process (GO:0009109) | 3.14441119 |
| 143 | intestinal epithelial cell development (GO:0060576) | 3.13755364 |
| 144 | icosanoid secretion (GO:0032309) | 3.12703251 |
| 145 | arachidonic acid secretion (GO:0050482) | 3.12703251 |
| 146 | quinone metabolic process (GO:1901661) | 3.12254960 |
| 147 | NLS-bearing protein import into nucleus (GO:0006607) | 3.10513196 |
| 148 | regulation of mast cell activation (GO:0033003) | 3.09012298 |
| 149 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.08805187 |
| 150 | regulation of telomere maintenance (GO:0032204) | 3.08689457 |
| 151 | myeloid dendritic cell differentiation (GO:0043011) | 3.07406277 |
| 152 | regulation of antigen processing and presentation (GO:0002577) | 3.06855406 |
| 153 | establishment of endothelial barrier (GO:0061028) | 3.06599416 |
| 154 | negative regulation of innate immune response (GO:0045824) | 3.06239702 |
| 155 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.06081383 |
| 156 | germinal center formation (GO:0002467) | 3.05612648 |
| 157 | vitamin A metabolic process (GO:0006776) | 3.04685977 |
| 158 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.02887606 |
| 159 | negative thymic T cell selection (GO:0045060) | 3.01824071 |
| 160 | positive regulation of macrophage cytokine production (GO:0060907) | 3.01797231 |
| 161 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.01238799 |
| 162 | response to protozoan (GO:0001562) | 3.01018455 |
| 163 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.98909603 |
| 164 | positive regulation of antigen processing and presentation (GO:0002579) | 2.98741019 |
| 165 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.98719893 |
| 166 | apoptotic DNA fragmentation (GO:0006309) | 2.98375093 |
| 167 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.97603324 |
| 168 | maternal placenta development (GO:0001893) | 2.96185115 |
| 169 | cullin deneddylation (GO:0010388) | 2.95347736 |
| 170 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.95285211 |
| 171 | cardiovascular system development (GO:0072358) | 2.94231503 |
| 172 | T-helper 1 type immune response (GO:0042088) | 2.94103583 |
| 173 | myeloid dendritic cell activation (GO:0001773) | 2.92394122 |
| 174 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.91584708 |
| 175 | pore complex assembly (GO:0046931) | 2.90950207 |
| 176 | positive regulation of B cell differentiation (GO:0045579) | 2.90844677 |
| 177 | negative T cell selection (GO:0043383) | 2.89664821 |
| 178 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.89283403 |
| 179 | adaptation of signaling pathway (GO:0023058) | 2.87558300 |
| 180 | macrophage activation (GO:0042116) | 2.87053597 |
| 181 | trophectodermal cell differentiation (GO:0001829) | 2.86315665 |
| 182 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.85969382 |
| 183 | cellular modified amino acid catabolic process (GO:0042219) | 2.85268580 |
| 184 | regulation of interleukin-12 production (GO:0032655) | 2.84893843 |
| 185 | neutrophil mediated immunity (GO:0002446) | 2.84717361 |
| 186 | positive regulation of B cell mediated immunity (GO:0002714) | 2.84682008 |
| 187 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.84682008 |
| 188 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.84627637 |
| 189 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.83940763 |
| 190 | regulation of T cell tolerance induction (GO:0002664) | 2.83195395 |
| 191 | negative regulation of peptidyl-serine phosphorylation (GO:0033137) | 2.82076767 |
| 192 | epoxygenase P450 pathway (GO:0019373) | 2.81331080 |
| 193 | negative regulation of interleukin-2 production (GO:0032703) | 2.80857708 |
| 194 | tolerance induction (GO:0002507) | 2.80311115 |
| 195 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.79946763 |
| 196 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.79881300 |
| 197 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.79534541 |
| 198 | positive thymic T cell selection (GO:0045059) | 2.78489981 |
| 199 | B cell homeostasis (GO:0001782) | 2.75797029 |
| 200 | regulation of cell killing (GO:0031341) | 2.73773249 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.30067463 |
| 2 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 5.93925459 |
| 3 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 5.93925459 |
| 4 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 5.93925459 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.54128533 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.27281471 |
| 7 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.64703110 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.40664265 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.32417945 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.30959563 |
| 11 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.11678559 |
| 12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.09049026 |
| 13 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.99778614 |
| 14 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.82266776 |
| 15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.79306643 |
| 16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.72154424 |
| 17 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.71706492 |
| 18 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.70050828 |
| 19 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.69677801 |
| 20 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.60564055 |
| 21 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.57535910 |
| 22 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.48459731 |
| 23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.48371520 |
| 24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.48146005 |
| 25 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.47599464 |
| 26 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.44614025 |
| 27 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.44003761 |
| 28 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.35666399 |
| 29 | MAF_26560356_Chip-Seq_TH1_Human | 2.31110814 |
| 30 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.27930619 |
| 31 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.27927589 |
| 32 | * TCF3_18692474_ChIP-Seq_MESCs_Mouse | 2.22488544 |
| 33 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.21196803 |
| 34 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.20173439 |
| 35 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.19835629 |
| 36 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.16739912 |
| 37 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.16716109 |
| 38 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 2.15193547 |
| 39 | MYB_26560356_Chip-Seq_TH2_Human | 2.14770070 |
| 40 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 2.10486096 |
| 41 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.09628244 |
| 42 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.04312676 |
| 43 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.97061482 |
| 44 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.96615722 |
| 45 | MYC_22102868_ChIP-Seq_BL_Human | 1.89193438 |
| 46 | MAF_26560356_Chip-Seq_TH2_Human | 1.88461983 |
| 47 | * NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.88276589 |
| 48 | UTX_26944678_Chip-Seq_JUKART_Human | 1.87766150 |
| 49 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.86177418 |
| 50 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.85178179 |
| 51 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.84801705 |
| 52 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.84398323 |
| 53 | MYB_26560356_Chip-Seq_TH1_Human | 1.81593944 |
| 54 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.80198138 |
| 55 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.77564206 |
| 56 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.74466666 |
| 57 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.73022299 |
| 58 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.67140962 |
| 59 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.66448967 |
| 60 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.65805472 |
| 61 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.65575989 |
| 62 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.61759916 |
| 63 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.61648232 |
| 64 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.60579630 |
| 65 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.56806583 |
| 66 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56793121 |
| 67 | * SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.54023787 |
| 68 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.53497567 |
| 69 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.53106233 |
| 70 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.52945305 |
| 71 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.52415418 |
| 72 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.51684893 |
| 73 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.51227523 |
| 74 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.51024253 |
| 75 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44948288 |
| 76 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44569096 |
| 77 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.43166833 |
| 78 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.42700795 |
| 79 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.41856806 |
| 80 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.41823347 |
| 81 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.41772884 |
| 82 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.41217644 |
| 83 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.40835286 |
| 84 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.39805217 |
| 85 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.39584400 |
| 86 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.39461932 |
| 87 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.38720365 |
| 88 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.38377369 |
| 89 | * NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.36923784 |
| 90 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.36848155 |
| 91 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36120361 |
| 92 | * POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.36086254 |
| 93 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.34689269 |
| 94 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.34555766 |
| 95 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.33801421 |
| 96 | GATA3_26560356_Chip-Seq_TH2_Human | 1.33746785 |
| 97 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.33334099 |
| 98 | * POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.32212383 |
| 99 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.30818277 |
| 100 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29876336 |
| 101 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.26088777 |
| 102 | KDM2B_26808549_Chip-Seq_K562_Human | 1.25520560 |
| 103 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.25014856 |
| 104 | * NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.23220570 |
| 105 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.22736850 |
| 106 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.21052079 |
| 107 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.20824744 |
| 108 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.20646389 |
| 109 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.20328407 |
| 110 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20114239 |
| 111 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.18518393 |
| 112 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.18381906 |
| 113 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 1.17979843 |
| 114 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.17650621 |
| 115 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.17519345 |
| 116 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.17068622 |
| 117 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.14893931 |
| 118 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.14390405 |
| 119 | * POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.14007890 |
| 120 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.13400395 |
| 121 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.12089006 |
| 122 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11904784 |
| 123 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.10501714 |
| 124 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.09514814 |
| 125 | * SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.07560674 |
| 126 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06710967 |
| 127 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.06607342 |
| 128 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.06404566 |
| 129 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.06242829 |
| 130 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.04000808 |
| 131 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.03941427 |
| 132 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.03081268 |
| 133 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.02345190 |
| 134 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 1.01516678 |
| 135 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.01331685 |
| 136 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.00302123 |
| 137 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.98827028 |
| 138 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.98093991 |
| 139 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.97528658 |
| 140 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.97309576 |
| 141 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.97257030 |
| 142 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.96993443 |
| 143 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.96141080 |
| 144 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.96065579 |
| 145 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.94150831 |
| 146 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.94008448 |
| 147 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.93825644 |
| 148 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.93168522 |
| 149 | P68_20966046_ChIP-Seq_HELA_Human | 0.92945291 |
| 150 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92293554 |
| 151 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.91716847 |
| 152 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.91184300 |
| 153 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.90864392 |
| 154 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.90753149 |
| 155 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.90623667 |
| 156 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.89484618 |
| 157 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.89104057 |
| 158 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88265772 |
| 159 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.87843452 |
| 160 | * SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.87713367 |
| 161 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.87684562 |
| 162 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.87242499 |
| 163 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.86558063 |
| 164 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.84961869 |
| 165 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.84787335 |
| 166 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.83843751 |
| 167 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.80530151 |
| 168 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.80453182 |
| 169 | * YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.80238065 |
| 170 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.78606478 |
| 171 | KAP1_27257070_Chip-Seq_ESCs_Mouse | 0.78283720 |
| 172 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.77181530 |
| 173 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.75387349 |
| 174 | SPI1_23127762_ChIP-Seq_K562_Human | 0.75293330 |
| 175 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.73887143 |
| 176 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.72885736 |
| 177 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.72108936 |
| 178 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.71947138 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002254_reproductive_system_inflammat | 5.31764007 |
| 2 | MP0006292_abnormal_olfactory_placode | 4.36791390 |
| 3 | MP0005671_abnormal_response_to | 4.18477738 |
| 4 | MP0003011_delayed_dark_adaptation | 3.91314819 |
| 5 | MP0005499_abnormal_olfactory_system | 3.84987664 |
| 6 | MP0005394_taste/olfaction_phenotype | 3.84987664 |
| 7 | MP0004858_abnormal_nervous_system | 3.77368366 |
| 8 | MP0003724_increased_susceptibility_to | 3.70472267 |
| 9 | MP0004264_abnormal_extraembryonic_tissu | 3.61905702 |
| 10 | MP0003890_abnormal_embryonic-extraembry | 3.30964194 |
| 11 | MP0003303_peritoneal_inflammation | 3.25718207 |
| 12 | MP0005000_abnormal_immune_tolerance | 3.21117801 |
| 13 | MP0009785_altered_susceptibility_to | 3.16233595 |
| 14 | MP0005025_abnormal_response_to | 2.95038067 |
| 15 | MP0002419_abnormal_innate_immunity | 2.93691606 |
| 16 | MP0003705_abnormal_hypodermis_morpholog | 2.93570801 |
| 17 | MP0002723_abnormal_immune_serum | 2.88068112 |
| 18 | MP0002148_abnormal_hypersensitivity_rea | 2.79411016 |
| 19 | MP0002452_abnormal_antigen_presenting | 2.77650663 |
| 20 | MP0005257_abnormal_intraocular_pressure | 2.74312224 |
| 21 | MP0002332_abnormal_exercise_endurance | 2.72787263 |
| 22 | MP0002420_abnormal_adaptive_immunity | 2.68587360 |
| 23 | MP0001819_abnormal_immune_cell | 2.66117841 |
| 24 | MP0002653_abnormal_ependyma_morphology | 2.65812143 |
| 25 | MP0008057_abnormal_DNA_replication | 2.51335228 |
| 26 | MP0005075_abnormal_melanosome_morpholog | 2.49703253 |
| 27 | MP0010352_gastrointestinal_tract_polyps | 2.40654369 |
| 28 | MP0004957_abnormal_blastocyst_morpholog | 2.39814037 |
| 29 | MP0003183_abnormal_peptide_metabolism | 2.19318039 |
| 30 | MP0001348_abnormal_lacrimal_gland | 2.16089129 |
| 31 | MP0003763_abnormal_thymus_physiology | 2.14788949 |
| 32 | MP0000716_abnormal_immune_system | 2.05503865 |
| 33 | MP0002398_abnormal_bone_marrow | 2.04122315 |
| 34 | MP0003122_maternal_imprinting | 2.03527169 |
| 35 | MP0009333_abnormal_splenocyte_physiolog | 1.97698145 |
| 36 | MP0008961_abnormal_basal_metabolism | 1.94524346 |
| 37 | MP0003191_abnormal_cellular_cholesterol | 1.93018601 |
| 38 | MP0001845_abnormal_inflammatory_respons | 1.91728949 |
| 39 | MP0006082_CNS_inflammation | 1.89454087 |
| 40 | MP0001533_abnormal_skeleton_physiology | 1.87558964 |
| 41 | MP0005058_abnormal_lysosome_morphology | 1.85749349 |
| 42 | MP0002277_abnormal_respiratory_mucosa | 1.83098667 |
| 43 | MP0000678_abnormal_parathyroid_gland | 1.78797768 |
| 44 | MP0005464_abnormal_platelet_physiology | 1.76811192 |
| 45 | MP0006035_abnormal_mitochondrial_morpho | 1.73078823 |
| 46 | MP0003121_genomic_imprinting | 1.70367490 |
| 47 | MP0001672_abnormal_embryogenesis/_devel | 1.69936311 |
| 48 | MP0005380_embryogenesis_phenotype | 1.69936311 |
| 49 | MP0003938_abnormal_ear_development | 1.68906310 |
| 50 | MP0003806_abnormal_nucleotide_metabolis | 1.67582824 |
| 51 | MP0002429_abnormal_blood_cell | 1.67218216 |
| 52 | MP0010155_abnormal_intestine_physiology | 1.65971010 |
| 53 | MP0001849_ear_inflammation | 1.63831772 |
| 54 | MP0004947_skin_inflammation | 1.63235079 |
| 55 | MP0003300_gastrointestinal_ulcer | 1.61434231 |
| 56 | MP0003172_abnormal_lysosome_physiology | 1.60865181 |
| 57 | MP0010030_abnormal_orbit_morphology | 1.60855229 |
| 58 | MP0008260_abnormal_autophagy | 1.60070055 |
| 59 | MP0008469_abnormal_protein_level | 1.57254596 |
| 60 | MP0009764_decreased_sensitivity_to | 1.56834679 |
| 61 | MP0002932_abnormal_joint_morphology | 1.53523630 |
| 62 | MP0008789_abnormal_olfactory_epithelium | 1.51686996 |
| 63 | MP0002088_abnormal_embryonic_growth/wei | 1.50927186 |
| 64 | MP0003984_embryonic_growth_retardation | 1.49609684 |
| 65 | MP0000350_abnormal_cell_proliferation | 1.48841993 |
| 66 | MP0002127_abnormal_cardiovascular_syste | 1.46258088 |
| 67 | MP0009840_abnormal_foam_cell | 1.43149944 |
| 68 | MP0001873_stomach_inflammation | 1.31964408 |
| 69 | MP0002132_abnormal_respiratory_system | 1.30968401 |
| 70 | MP0001293_anophthalmia | 1.30528331 |
| 71 | MP0003283_abnormal_digestive_organ | 1.30516351 |
| 72 | MP0003077_abnormal_cell_cycle | 1.27246902 |
| 73 | MP0005451_abnormal_body_composition | 1.25265536 |
| 74 | MP0000703_abnormal_thymus_morphology | 1.25248078 |
| 75 | MP0005310_abnormal_salivary_gland | 1.24935847 |
| 76 | MP0001853_heart_inflammation | 1.23292805 |
| 77 | MP0002085_abnormal_embryonic_tissue | 1.21302409 |
| 78 | MP0003866_abnormal_defecation | 1.19328955 |
| 79 | MP0002092_abnormal_eye_morphology | 1.19099041 |
| 80 | MP0002086_abnormal_extraembryonic_tissu | 1.15363222 |
| 81 | MP0000465_gastrointestinal_hemorrhage | 1.14682113 |
| 82 | MP0003075_altered_response_to | 1.09260074 |
| 83 | MP0003111_abnormal_nucleus_morphology | 1.07162511 |
| 84 | MP0005248_abnormal_Harderian_gland | 1.06530347 |
| 85 | MP0004510_myositis | 1.06403828 |
| 86 | MP0002084_abnormal_developmental_patter | 1.06055416 |
| 87 | MP0002998_abnormal_bone_remodeling | 1.05360262 |
| 88 | MP0004883_abnormal_blood_vessel | 1.03966624 |
| 89 | MP0002970_abnormal_white_adipose | 0.97985719 |
| 90 | MP0008770_decreased_survivor_rate | 0.97449892 |
| 91 | MP0002233_abnormal_nose_morphology | 0.95302408 |
| 92 | MP0002138_abnormal_hepatobiliary_system | 0.95075882 |
| 93 | MP0003828_pulmonary_edema | 0.94883301 |
| 94 | MP0000604_amyloidosis | 0.93008794 |
| 95 | MP0009763_increased_sensitivity_to | 0.92607081 |
| 96 | MP0003315_abnormal_perineum_morphology | 0.92569556 |
| 97 | MP0009278_abnormal_bone_marrow | 0.92188815 |
| 98 | MP0000428_abnormal_craniofacial_morphol | 0.91698258 |
| 99 | MP0002114_abnormal_axial_skeleton | 0.90584123 |
| 100 | MP0004381_abnormal_hair_follicle | 0.90021090 |
| 101 | MP0003448_altered_tumor_morphology | 0.89769593 |
| 102 | MP0001730_embryonic_growth_arrest | 0.89470052 |
| 103 | MP0005266_abnormal_metabolism | 0.89416176 |
| 104 | MP0000049_abnormal_middle_ear | 0.88571115 |
| 105 | MP0000762_abnormal_tongue_morphology | 0.87518812 |
| 106 | MP0002166_altered_tumor_susceptibility | 0.87407495 |
| 107 | MP0001851_eye_inflammation | 0.86695993 |
| 108 | MP0001663_abnormal_digestive_system | 0.86500266 |
| 109 | MP0000313_abnormal_cell_death | 0.86289861 |
| 110 | MP0003755_abnormal_palate_morphology | 0.86000515 |
| 111 | MP0003935_abnormal_craniofacial_develop | 0.84739127 |
| 112 | MP0005397_hematopoietic_system_phenotyp | 0.83247692 |
| 113 | MP0001545_abnormal_hematopoietic_system | 0.83247692 |
| 114 | MP0005167_abnormal_blood-brain_barrier | 0.83138287 |
| 115 | MP0001790_abnormal_immune_system | 0.80044116 |
| 116 | MP0005387_immune_system_phenotype | 0.80044116 |
| 117 | MP0002396_abnormal_hematopoietic_system | 0.79109840 |
| 118 | MP0005166_decreased_susceptibility_to | 0.78223032 |
| 119 | MP0002925_abnormal_cardiovascular_devel | 0.77893675 |
| 120 | MP0000750_abnormal_muscle_regeneration | 0.77739024 |
| 121 | MP0000432_abnormal_head_morphology | 0.77641522 |
| 122 | MP0005023_abnormal_wound_healing | 0.77295956 |
| 123 | MP0000858_altered_metastatic_potential | 0.76673171 |
| 124 | MP0001697_abnormal_embryo_size | 0.75478093 |
| 125 | MP0000490_abnormal_crypts_of | 0.74916629 |
| 126 | MP0002080_prenatal_lethality | 0.74661836 |
| 127 | MP0003119_abnormal_digestive_system | 0.74291400 |
| 128 | MP0003566_abnormal_cell_adhesion | 0.74154293 |
| 129 | MP0003436_decreased_susceptibility_to | 0.73690369 |
| 130 | MP0005197_abnormal_uvea_morphology | 0.72684975 |
| 131 | MP0003221_abnormal_cardiomyocyte_apopto | 0.71994347 |
| 132 | MP0008932_abnormal_embryonic_tissue | 0.71302895 |
| 133 | MP0000015_abnormal_ear_pigmentation | 0.70617773 |
| 134 | MP0009765_abnormal_xenobiotic_induced | 0.70472349 |
| 135 | MP0005390_skeleton_phenotype | 0.70438302 |
| 136 | MP0005164_abnormal_response_to | 0.70309041 |
| 137 | MP0003123_paternal_imprinting | 0.70084120 |
| 138 | MP0003091_abnormal_cell_migration | 0.69382219 |
| 139 | MP0001800_abnormal_humoral_immune | 0.69192533 |
| 140 | MP0003787_abnormal_imprinting | 0.68539320 |
| 141 | MP0002751_abnormal_autonomic_nervous | 0.67832805 |
| 142 | MP0004197_abnormal_fetal_growth/weight/ | 0.67771540 |
| 143 | MP0005508_abnormal_skeleton_morphology | 0.67167437 |
| 144 | MP0008874_decreased_physiological_sensi | 0.66913692 |
| 145 | MP0005384_cellular_phenotype | 0.66623634 |
| 146 | MP0002405_respiratory_system_inflammati | 0.66030716 |
| 147 | MP0003137_abnormal_impulse_conducting | 0.65197545 |
| 148 | MP0008995_early_reproductive_senescence | 0.63403638 |
| 149 | MP0010094_abnormal_chromosome_stability | 0.63256325 |
| 150 | MP0002163_abnormal_gland_morphology | 0.63139790 |
| 151 | MP0005621_abnormal_cell_physiology | 0.62578549 |
| 152 | MP0005391_vision/eye_phenotype | 0.62576238 |
| 153 | MP0002116_abnormal_craniofacial_bone | 0.62367905 |
| 154 | MP0000358_abnormal_cell_content/ | 0.62049417 |
| 155 | MP0002693_abnormal_pancreas_physiology | 0.61569186 |
| 156 | MP0000343_altered_response_to | 0.61511209 |
| 157 | MP0003861_abnormal_nervous_system | 0.59957051 |
| 158 | MP0002006_tumorigenesis | 0.59721431 |
| 159 | MP0005319_abnormal_enzyme/_coenzyme | 0.59655914 |
| 160 | MP0002019_abnormal_tumor_incidence | 0.59027715 |
| 161 | MP0001835_abnormal_antigen_presentation | 0.58399530 |
| 162 | MP0003656_abnormal_erythrocyte_physiolo | 0.57701719 |
| 163 | MP0003795_abnormal_bone_structure | 0.57419623 |
| 164 | MP0003937_abnormal_limbs/digits/tail_de | 0.56605469 |
| 165 | MP0000609_abnormal_liver_physiology | 0.56318913 |
| 166 | MP0002081_perinatal_lethality | 0.56311886 |
| 167 | MP0000685_abnormal_immune_system | 0.55670707 |
| 168 | MP0002722_abnormal_immune_system | 0.54046918 |
| 169 | MP0000689_abnormal_spleen_morphology | 0.53606437 |
| 170 | MP0000249_abnormal_blood_vessel | 0.52993769 |
| 171 | MP0003786_premature_aging | 0.51522402 |
| 172 | MP0001986_abnormal_taste_sensitivity | 0.49000268 |
| 173 | MP0008873_increased_physiological_sensi | 0.48988127 |
| 174 | MP0005084_abnormal_gallbladder_morpholo | 0.45838530 |
| 175 | MP0006036_abnormal_mitochondrial_physio | 0.45281392 |
| 176 | MP0005381_digestive/alimentary_phenotyp | 0.44817882 |
| 177 | MP0001542_abnormal_bone_strength | 0.44144162 |
| 178 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.43323913 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Bilateral microphthalmos (HP:0007633) | 7.06430311 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 5.58844017 |
| 3 | Abnormality of macrophages (HP:0004311) | 5.55173404 |
| 4 | Recurrent abscess formation (HP:0002722) | 5.41347336 |
| 5 | Eczematoid dermatitis (HP:0000976) | 5.36207049 |
| 6 | Hypochromic microcytic anemia (HP:0004840) | 5.30999500 |
| 7 | Hepatoblastoma (HP:0002884) | 5.29599464 |
| 8 | Abnormality of the lower motor neuron (HP:0002366) | 5.27060416 |
| 9 | Mediastinal lymphadenopathy (HP:0100721) | 4.63584504 |
| 10 | Rib fusion (HP:0000902) | 4.61997765 |
| 11 | Multiple enchondromatosis (HP:0005701) | 4.54451409 |
| 12 | Optic neuritis (HP:0100653) | 4.42442184 |
| 13 | Retrobulbar optic neuritis (HP:0100654) | 4.42442184 |
| 14 | Orchitis (HP:0100796) | 4.40697294 |
| 15 | Myositis (HP:0100614) | 4.36650406 |
| 16 | Stomatitis (HP:0010280) | 4.35361788 |
| 17 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.07882115 |
| 18 | Ependymoma (HP:0002888) | 4.00481351 |
| 19 | Recurrent skin infections (HP:0001581) | 3.99332655 |
| 20 | Recurrent fungal infections (HP:0002841) | 3.95068032 |
| 21 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.85117690 |
| 22 | Recurrent cutaneous fungal infections (HP:0011370) | 3.85117690 |
| 23 | Meningitis (HP:0001287) | 3.82530987 |
| 24 | Chronic obstructive pulmonary disease (HP:0006510) | 3.80062694 |
| 25 | Obstructive lung disease (HP:0006536) | 3.80062694 |
| 26 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.74698683 |
| 27 | Vasculitis (HP:0002633) | 3.74064106 |
| 28 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.64608309 |
| 29 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.64104613 |
| 30 | Urticaria (HP:0001025) | 3.54512710 |
| 31 | Testicular atrophy (HP:0000029) | 3.54258753 |
| 32 | Neoplasm of striated muscle (HP:0009728) | 3.50506563 |
| 33 | Vacuolated lymphocytes (HP:0001922) | 3.45883612 |
| 34 | Increased IgM level (HP:0003496) | 3.44289780 |
| 35 | Gastrointestinal infarctions (HP:0005244) | 3.37519678 |
| 36 | Gastrointestinal stroma tumor (HP:0100723) | 3.34699646 |
| 37 | Amyotrophic lateral sclerosis (HP:0007354) | 3.32276091 |
| 38 | Encephalitis (HP:0002383) | 3.27505188 |
| 39 | Pulmonary infiltrates (HP:0002113) | 3.23807154 |
| 40 | Nephroblastoma (Wilms tumor) (HP:0002667) | 3.16395975 |
| 41 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.15168518 |
| 42 | Hypoplasia of the fovea (HP:0007750) | 3.15168518 |
| 43 | Rhabdomyosarcoma (HP:0002859) | 3.11756680 |
| 44 | Increased cerebral lipofuscin (HP:0011813) | 3.11399600 |
| 45 | Recurrent viral infections (HP:0004429) | 3.10663580 |
| 46 | Fused cervical vertebrae (HP:0002949) | 3.08813786 |
| 47 | Lymphopenia (HP:0001888) | 3.08438691 |
| 48 | Autoimmune thrombocytopenia (HP:0001973) | 3.07127735 |
| 49 | Chromsome breakage (HP:0040012) | 3.05096799 |
| 50 | Abnormality of T cells (HP:0002843) | 2.96129729 |
| 51 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.95326842 |
| 52 | Keratoconjunctivitis sicca (HP:0001097) | 2.93044170 |
| 53 | Astrocytoma (HP:0009592) | 2.91993435 |
| 54 | Abnormality of the astrocytes (HP:0100707) | 2.91993435 |
| 55 | Hemoptysis (HP:0002105) | 2.91047122 |
| 56 | Embryonal renal neoplasm (HP:0011794) | 2.89746554 |
| 57 | Generalized hypotonia (HP:0001290) | 2.88084023 |
| 58 | Keratoconjunctivitis (HP:0001096) | 2.87721033 |
| 59 | Abnormality of T cell number (HP:0011839) | 2.86825100 |
| 60 | Recurrent sinusitis (HP:0011108) | 2.80915576 |
| 61 | Abnormality of the phalanges of the hallux (HP:0010057) | 2.76389525 |
| 62 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.74407579 |
| 63 | Bifid tongue (HP:0010297) | 2.73915910 |
| 64 | Abnormality of T cell physiology (HP:0011840) | 2.72193257 |
| 65 | Shawl scrotum (HP:0000049) | 2.71826851 |
| 66 | Short humerus (HP:0005792) | 2.71574788 |
| 67 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.71129890 |
| 68 | T lymphocytopenia (HP:0005403) | 2.70381931 |
| 69 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.67823300 |
| 70 | Hypochromic anemia (HP:0001931) | 2.63097046 |
| 71 | Trismus (HP:0000211) | 2.61920079 |
| 72 | Loss of speech (HP:0002371) | 2.61706477 |
| 73 | Rectal fistula (HP:0100590) | 2.60517804 |
| 74 | Rectovaginal fistula (HP:0000143) | 2.60517804 |
| 75 | Hand muscle atrophy (HP:0009130) | 2.59910068 |
| 76 | Large earlobe (HP:0009748) | 2.59275014 |
| 77 | Chest pain (HP:0100749) | 2.57920735 |
| 78 | Nasal polyposis (HP:0100582) | 2.57314027 |
| 79 | Intestinal fistula (HP:0100819) | 2.56846265 |
| 80 | Horizontal nystagmus (HP:0000666) | 2.54393602 |
| 81 | Neoplasm of the heart (HP:0100544) | 2.54289855 |
| 82 | Cellulitis (HP:0100658) | 2.51232524 |
| 83 | IgG deficiency (HP:0004315) | 2.50677293 |
| 84 | Gingivitis (HP:0000230) | 2.49693002 |
| 85 | Abnormal lung lobation (HP:0002101) | 2.49410930 |
| 86 | Preauricular skin tag (HP:0000384) | 2.49335230 |
| 87 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.48912122 |
| 88 | Panhypogammaglobulinemia (HP:0003139) | 2.46911828 |
| 89 | Abnormality of the fovea (HP:0000493) | 2.46586225 |
| 90 | Leukocytosis (HP:0001974) | 2.46562783 |
| 91 | Spontaneous hematomas (HP:0007420) | 2.45852770 |
| 92 | Abnormality of the salivary glands (HP:0010286) | 2.45189606 |
| 93 | Anomalous pulmonary venous return (HP:0010772) | 2.44914747 |
| 94 | Anorexia (HP:0002039) | 2.44378324 |
| 95 | Progressive neurologic deterioration (HP:0002344) | 2.44059120 |
| 96 | Agammaglobulinemia (HP:0004432) | 2.43234812 |
| 97 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 2.42917691 |
| 98 | Abnormal cartilage morphology (HP:0002763) | 2.42454010 |
| 99 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.41219758 |
| 100 | Increased IgE level (HP:0003212) | 2.40090841 |
| 101 | Ragged-red muscle fibers (HP:0003200) | 2.39730454 |
| 102 | Granulocytopenia (HP:0001913) | 2.38667378 |
| 103 | Meckel diverticulum (HP:0002245) | 2.37954160 |
| 104 | IgM deficiency (HP:0002850) | 2.37675800 |
| 105 | Mutism (HP:0002300) | 2.37263695 |
| 106 | Pustule (HP:0200039) | 2.34634493 |
| 107 | Preauricular pit (HP:0004467) | 2.33533973 |
| 108 | Periauricular skin pits (HP:0100277) | 2.33533973 |
| 109 | Petechiae (HP:0000967) | 2.32455855 |
| 110 | Skin tags (HP:0010609) | 2.31461647 |
| 111 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.28272462 |
| 112 | Villous atrophy (HP:0011473) | 2.28272462 |
| 113 | Vaginal fistula (HP:0004320) | 2.27693138 |
| 114 | Abnormality of the pubic bones (HP:0003172) | 2.26036967 |
| 115 | Abnormality of chromosome segregation (HP:0002916) | 2.25842283 |
| 116 | Renal duplication (HP:0000075) | 2.24891600 |
| 117 | Partial duplication of thumb phalanx (HP:0009944) | 2.24603028 |
| 118 | Upper motor neuron abnormality (HP:0002127) | 2.24190392 |
| 119 | Increased serum ferritin (HP:0003281) | 2.24183111 |
| 120 | Difficulty running (HP:0009046) | 2.22911316 |
| 121 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.22319364 |
| 122 | Hepatosplenomegaly (HP:0001433) | 2.21149750 |
| 123 | Abnormality of the ileum (HP:0001549) | 2.20672284 |
| 124 | Abnormality of the nasal mucosa (HP:0000433) | 2.19814264 |
| 125 | Hypertensive crisis (HP:0100735) | 2.18646438 |
| 126 | Hypergammaglobulinemia (HP:0010702) | 2.18510920 |
| 127 | Dysostosis multiplex (HP:0000943) | 2.17633065 |
| 128 | Restrictive lung disease (HP:0002091) | 2.17349783 |
| 129 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.17199076 |
| 130 | Abnormality of the musculature of the hand (HP:0001421) | 2.16785395 |
| 131 | Gangrene (HP:0100758) | 2.16138004 |
| 132 | Episodic fever (HP:0001954) | 2.15197857 |
| 133 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.15086626 |
| 134 | Acute hepatic failure (HP:0006554) | 2.15002893 |
| 135 | Tetraplegia (HP:0002445) | 2.14723385 |
| 136 | Hypopigmentation of the fundus (HP:0007894) | 2.14435587 |
| 137 | Distal upper limb amyotrophy (HP:0007149) | 2.14285681 |
| 138 | Upper limb amyotrophy (HP:0009129) | 2.14285681 |
| 139 | Joint swelling (HP:0001386) | 2.14150630 |
| 140 | Disinhibition (HP:0000734) | 2.13222019 |
| 141 | Arterial thrombosis (HP:0004420) | 2.13082422 |
| 142 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.12915079 |
| 143 | Eosinophilia (HP:0001880) | 2.11772725 |
| 144 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.10037505 |
| 145 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.10037505 |
| 146 | Abnormality of glycolipid metabolism (HP:0010969) | 2.10037505 |
| 147 | Premature ovarian failure (HP:0008209) | 2.09819999 |
| 148 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.09702587 |
| 149 | Progressive muscle weakness (HP:0003323) | 2.09248078 |
| 150 | Upper limb muscle weakness (HP:0003484) | 2.08611395 |
| 151 | Achilles tendon contracture (HP:0001771) | 2.08520367 |
| 152 | IgA deficiency (HP:0002720) | 2.08317931 |
| 153 | Inflammation of the large intestine (HP:0002037) | 2.07710524 |
| 154 | Abnormality of eosinophils (HP:0001879) | 2.07469254 |
| 155 | Cheilitis (HP:0100825) | 2.07189590 |
| 156 | Increased connective tissue (HP:0009025) | 2.06048090 |
| 157 | Sepsis (HP:0100806) | 2.05408884 |
| 158 | Abnormality of the pleura (HP:0002103) | 2.04194232 |
| 159 | Recurrent bronchitis (HP:0002837) | 2.03342340 |
| 160 | Tongue fasciculations (HP:0001308) | 2.02705764 |
| 161 | Recurrent pneumonia (HP:0006532) | 2.01416093 |
| 162 | Leukopenia (HP:0001882) | 2.00548648 |
| 163 | Sensory axonal neuropathy (HP:0003390) | 2.00454485 |
| 164 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.98644718 |
| 165 | Abnormality of the pulmonary veins (HP:0011718) | 1.98298682 |
| 166 | Short 5th finger (HP:0009237) | 1.97642173 |
| 167 | Gastrointestinal inflammation (HP:0004386) | 1.97332392 |
| 168 | Pendular nystagmus (HP:0012043) | 1.97157584 |
| 169 | Arthralgia (HP:0002829) | 1.96213550 |
| 170 | Pulmonary embolism (HP:0002204) | 1.95679798 |
| 171 | Polyneuropathy (HP:0001271) | 1.94672214 |
| 172 | Osteomyelitis (HP:0002754) | 1.94630952 |
| 173 | Glomerulopathy (HP:0100820) | 1.93903787 |
| 174 | Partial duplication of the phalanx of hand (HP:0009999) | 1.93822262 |
| 175 | Skin rash (HP:0000988) | 1.93446831 |
| 176 | Recurrent lower respiratory tract infections (HP:0002783) | 1.92808441 |
| 177 | Pseudobulbar signs (HP:0002200) | 1.92796410 |
| 178 | Amblyopia (HP:0000646) | 1.92312623 |
| 179 | Aplastic anemia (HP:0001915) | 1.91123801 |
| 180 | Abnormality of iron homeostasis (HP:0011031) | 1.91123132 |
| 181 | Skin pits (HP:0100276) | 1.90994299 |
| 182 | Duodenal stenosis (HP:0100867) | 1.90961181 |
| 183 | Small intestinal stenosis (HP:0012848) | 1.90961181 |
| 184 | Impulsivity (HP:0100710) | 1.90623664 |
| 185 | Muscle fibrillation (HP:0010546) | 1.90502944 |
| 186 | Emphysema (HP:0002097) | 1.89732832 |
| 187 | Peritonitis (HP:0002586) | 1.89052949 |
| 188 | Combined immunodeficiency (HP:0005387) | 1.88373904 |
| 189 | Malignant neoplasm of the central nervous system (HP:0100836) | 1.88113981 |
| 190 | Chronic otitis media (HP:0000389) | 1.88021863 |
| 191 | Glioma (HP:0009733) | 1.87113771 |
| 192 | Chronic diarrhea (HP:0002028) | 1.87113232 |
| 193 | Reduced antithrombin III activity (HP:0001976) | 1.87041247 |
| 194 | Abnormality of the endocardium (HP:0004306) | 1.86448588 |
| 195 | Fasciculations (HP:0002380) | 1.86166548 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 7.80458218 |
| 2 | GRK5 | 5.00303110 |
| 3 | MAP4K1 | 4.88391386 |
| 4 | ERN1 | 4.75083055 |
| 5 | GRK6 | 4.21618277 |
| 6 | TAOK3 | 3.56252934 |
| 7 | TXK | 3.24034025 |
| 8 | IRAK4 | 3.06448500 |
| 9 | ADRBK2 | 3.03149176 |
| 10 | GRK1 | 2.72328866 |
| 11 | CSF1R | 2.71935771 |
| 12 | TYRO3 | 2.60646974 |
| 13 | MOS | 2.40899053 |
| 14 | STK10 | 2.38766799 |
| 15 | TTK | 2.28517794 |
| 16 | TGFBR2 | 2.25637682 |
| 17 | MAP3K14 | 2.21064362 |
| 18 | TBK1 | 2.18152847 |
| 19 | MATK | 2.14053301 |
| 20 | IKBKE | 2.13610626 |
| 21 | WNK1 | 1.99254764 |
| 22 | MAPK7 | 1.97688207 |
| 23 | MAP2K3 | 1.94807948 |
| 24 | JAK3 | 1.84422724 |
| 25 | SIK3 | 1.76134189 |
| 26 | FGR | 1.72695455 |
| 27 | SYK | 1.66674872 |
| 28 | MAP3K10 | 1.66481137 |
| 29 | GRK7 | 1.65726029 |
| 30 | ZAP70 | 1.64746096 |
| 31 | MAP3K11 | 1.63079655 |
| 32 | NTRK1 | 1.62491389 |
| 33 | FES | 1.60259960 |
| 34 | MAP3K9 | 1.58974466 |
| 35 | MAP3K3 | 1.55308687 |
| 36 | LYN | 1.50273257 |
| 37 | MARK2 | 1.49541407 |
| 38 | CAMK4 | 1.43740344 |
| 39 | BTK | 1.42644972 |
| 40 | JAK1 | 1.40089238 |
| 41 | FGFR3 | 1.38447634 |
| 42 | TNK2 | 1.36803983 |
| 43 | PRKG2 | 1.28196195 |
| 44 | EPHB1 | 1.27876712 |
| 45 | PAK4 | 1.27655315 |
| 46 | BMPR2 | 1.19388219 |
| 47 | LATS2 | 1.17767680 |
| 48 | CDK7 | 1.16492648 |
| 49 | HIPK2 | 1.16484045 |
| 50 | KIT | 1.13325788 |
| 51 | CHEK2 | 1.09883953 |
| 52 | ALK | 1.09626998 |
| 53 | LCK | 1.08973633 |
| 54 | BCKDK | 1.05887005 |
| 55 | MAP2K4 | 1.03103621 |
| 56 | EPHA2 | 1.01027777 |
| 57 | NME2 | 0.99216691 |
| 58 | CSK | 0.96901986 |
| 59 | PRKCQ | 0.95608394 |
| 60 | SIK2 | 0.94590530 |
| 61 | MAP3K7 | 0.94439794 |
| 62 | PIM2 | 0.94332330 |
| 63 | ADRBK1 | 0.93472729 |
| 64 | SMG1 | 0.87762936 |
| 65 | PLK1 | 0.83325634 |
| 66 | CDK19 | 0.82353215 |
| 67 | IRAK3 | 0.81805044 |
| 68 | EPHA3 | 0.80188696 |
| 69 | TRIB3 | 0.77335212 |
| 70 | MAP3K1 | 0.76989649 |
| 71 | NEK2 | 0.74906625 |
| 72 | MAP3K5 | 0.72770014 |
| 73 | TEC | 0.70442438 |
| 74 | PRKD2 | 0.69842583 |
| 75 | MAP3K13 | 0.68564509 |
| 76 | TAOK1 | 0.68413631 |
| 77 | PDK1 | 0.68309366 |
| 78 | CHEK1 | 0.66447393 |
| 79 | TESK2 | 0.65943615 |
| 80 | IRAK2 | 0.65861175 |
| 81 | STK16 | 0.65715119 |
| 82 | PIM1 | 0.64675332 |
| 83 | IRAK1 | 0.63718014 |
| 84 | BLK | 0.62910610 |
| 85 | IKBKB | 0.61291741 |
| 86 | STK38 | 0.59192628 |
| 87 | DAPK2 | 0.57882044 |
| 88 | DYRK2 | 0.57424835 |
| 89 | PTK2 | 0.57165591 |
| 90 | PRKD3 | 0.55987902 |
| 91 | PDPK1 | 0.55807392 |
| 92 | MTOR | 0.54939350 |
| 93 | MAP2K6 | 0.53951586 |
| 94 | STK24 | 0.53183891 |
| 95 | AKT2 | 0.53102042 |
| 96 | ARAF | 0.49195146 |
| 97 | CAMKK2 | 0.48853491 |
| 98 | RIPK1 | 0.48555881 |
| 99 | MAPK12 | 0.48021067 |
| 100 | NEK9 | 0.47783607 |
| 101 | PTK2B | 0.46923954 |
| 102 | PAK6 | 0.45818109 |
| 103 | CDC42BPA | 0.45138719 |
| 104 | YES1 | 0.44524573 |
| 105 | CCNB1 | 0.44331989 |
| 106 | BMX | 0.42914607 |
| 107 | ZAK | 0.42894592 |
| 108 | CHUK | 0.42821991 |
| 109 | AKT3 | 0.41937270 |
| 110 | DYRK3 | 0.40073683 |
| 111 | EIF2AK2 | 0.40058118 |
| 112 | FYN | 0.38798647 |
| 113 | RPS6KA6 | 0.37745403 |
| 114 | KSR2 | 0.37205155 |
| 115 | RPS6KL1 | 0.37038936 |
| 116 | RPS6KC1 | 0.37038936 |
| 117 | CDK2 | 0.36625889 |
| 118 | MAPKAPK3 | 0.36526425 |
| 119 | DYRK1B | 0.35236209 |
| 120 | PRKCI | 0.35189923 |
| 121 | ITK | 0.34651273 |
| 122 | MAPK11 | 0.34188089 |
| 123 | TYK2 | 0.33714722 |
| 124 | PIK3CG | 0.33280924 |
| 125 | AURKA | 0.32716746 |
| 126 | PAK1 | 0.32546898 |
| 127 | PRKCD | 0.32287383 |
| 128 | NME1 | 0.32055047 |
| 129 | TLK1 | 0.31465404 |
| 130 | IGF1R | 0.30367087 |
| 131 | MAPK10 | 0.27775055 |
| 132 | RIPK4 | 0.27484986 |
| 133 | HCK | 0.26972945 |
| 134 | DYRK1A | 0.26277458 |
| 135 | ABL1 | 0.26186691 |
| 136 | PRKCZ | 0.26012354 |
| 137 | RAF1 | 0.25177385 |
| 138 | FGFR4 | 0.24694491 |
| 139 | LIMK1 | 0.24662325 |
| 140 | PRPF4B | 0.23958559 |
| 141 | INSR | 0.23281955 |
| 142 | CDK4 | 0.22894913 |
| 143 | ATM | 0.21250267 |
| 144 | PRKAA1 | 0.20607205 |
| 145 | ERBB2 | 0.20227250 |
| 146 | PDGFRA | 0.18655165 |
| 147 | MAP3K8 | 0.18483163 |
| 148 | PAK3 | 0.18280109 |
| 149 | GSK3B | 0.18134844 |
| 150 | BUB1 | 0.17618888 |
| 151 | TAOK2 | 0.17574135 |
| 152 | JAK2 | 0.17318966 |
| 153 | MAPK1 | 0.16167104 |
| 154 | MARK3 | 0.15553762 |
| 155 | ICK | 0.14959168 |
| 156 | LATS1 | 0.14764319 |
| 157 | CDK1 | 0.14581996 |
| 158 | CSNK1E | 0.14507768 |
| 159 | CDK15 | 0.14401888 |
| 160 | MAPKAPK2 | 0.12342432 |
| 161 | CAMK1D | 0.12322296 |
| 162 | MAPK14 | 0.12276526 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 5.20602040 |
| 2 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 5.03208984 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.67100901 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.39415620 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.23428878 |
| 6 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.81709880 |
| 7 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.77102908 |
| 8 | Asthma_Homo sapiens_hsa05310 | 2.76669973 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.67769981 |
| 10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.58829036 |
| 11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.57749971 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.35264758 |
| 13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.33165155 |
| 14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.31021564 |
| 15 | mTOR signaling pathway_Homo sapiens_hsa04150 | 2.04865007 |
| 16 | Viral myocarditis_Homo sapiens_hsa05416 | 1.91317130 |
| 17 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.87935957 |
| 18 | Measles_Homo sapiens_hsa05162 | 1.86720570 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.76078751 |
| 20 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.70800460 |
| 21 | Galactose metabolism_Homo sapiens_hsa00052 | 1.66523376 |
| 22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.60566075 |
| 23 | Lysosome_Homo sapiens_hsa04142 | 1.59993911 |
| 24 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.57497301 |
| 25 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.54260036 |
| 26 | Phagosome_Homo sapiens_hsa04145 | 1.46845374 |
| 27 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.45958651 |
| 28 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.41207867 |
| 29 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.39891516 |
| 30 | Thyroid cancer_Homo sapiens_hsa05216 | 1.39780683 |
| 31 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.39330749 |
| 32 | Legionellosis_Homo sapiens_hsa05134 | 1.35137093 |
| 33 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.33223848 |
| 34 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.32644310 |
| 35 | Malaria_Homo sapiens_hsa05144 | 1.32010535 |
| 36 | Other glycan degradation_Homo sapiens_hsa00511 | 1.24657807 |
| 37 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.24561948 |
| 38 | Shigellosis_Homo sapiens_hsa05131 | 1.22521296 |
| 39 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.21908399 |
| 40 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.20665951 |
| 41 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.20629077 |
| 42 | RNA transport_Homo sapiens_hsa03013 | 1.20211746 |
| 43 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.17099446 |
| 44 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.16906981 |
| 45 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.15945262 |
| 46 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.12963693 |
| 47 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.12858248 |
| 48 | Cell cycle_Homo sapiens_hsa04110 | 1.10967692 |
| 49 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.10794387 |
| 50 | Hepatitis B_Homo sapiens_hsa05161 | 1.09416467 |
| 51 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.09249292 |
| 52 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.08619934 |
| 53 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.08599068 |
| 54 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.07742206 |
| 55 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.06913538 |
| 56 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.06628362 |
| 57 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.06322607 |
| 58 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.06013922 |
| 59 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.04881391 |
| 60 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.04270854 |
| 61 | Apoptosis_Homo sapiens_hsa04210 | 1.03910999 |
| 62 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.00780269 |
| 63 | Sulfur relay system_Homo sapiens_hsa04122 | 0.99692621 |
| 64 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.99552820 |
| 65 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.98835751 |
| 66 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.95539928 |
| 67 | Pertussis_Homo sapiens_hsa05133 | 0.95095925 |
| 68 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.94281243 |
| 69 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.93654471 |
| 70 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.92771066 |
| 71 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.92591043 |
| 72 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.90592196 |
| 73 | Salmonella infection_Homo sapiens_hsa05132 | 0.89203080 |
| 74 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.88988381 |
| 75 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.88429751 |
| 76 | Pathways in cancer_Homo sapiens_hsa05200 | 0.88031493 |
| 77 | Bladder cancer_Homo sapiens_hsa05219 | 0.87660092 |
| 78 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.87304828 |
| 79 | Leishmaniasis_Homo sapiens_hsa05140 | 0.86558025 |
| 80 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.85630824 |
| 81 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.84784999 |
| 82 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.84332263 |
| 83 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.83653301 |
| 84 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.81942281 |
| 85 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.78333298 |
| 86 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.77994564 |
| 87 | Influenza A_Homo sapiens_hsa05164 | 0.76393554 |
| 88 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.75879114 |
| 89 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.75038865 |
| 90 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.74826620 |
| 91 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.72476760 |
| 92 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.71690339 |
| 93 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.70965549 |
| 94 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.70583388 |
| 95 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.68742575 |
| 96 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.68328958 |
| 97 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.67874839 |
| 98 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.66788696 |
| 99 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.66545628 |
| 100 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.65874931 |
| 101 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.63411727 |
| 102 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.60758109 |
| 103 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.60184765 |
| 104 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.59947807 |
| 105 | HTLV-I infection_Homo sapiens_hsa05166 | 0.58363263 |
| 106 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.58084296 |
| 107 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.58022064 |
| 108 | Colorectal cancer_Homo sapiens_hsa05210 | 0.57641491 |
| 109 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.56925929 |
| 110 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.56872832 |
| 111 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.56719202 |
| 112 | Proteasome_Homo sapiens_hsa03050 | 0.53078495 |
| 113 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.51931898 |
| 114 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.51859248 |
| 115 | RNA degradation_Homo sapiens_hsa03018 | 0.51763202 |
| 116 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.49986407 |
| 117 | Glioma_Homo sapiens_hsa05214 | 0.49614689 |
| 118 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.49075329 |
| 119 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.48704429 |
| 120 | Endometrial cancer_Homo sapiens_hsa05213 | 0.47522727 |
| 121 | Hepatitis C_Homo sapiens_hsa05160 | 0.46882385 |
| 122 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.46632897 |
| 123 | Tuberculosis_Homo sapiens_hsa05152 | 0.46539996 |
| 124 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.46279116 |
| 125 | Endocytosis_Homo sapiens_hsa04144 | 0.45741596 |
| 126 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.44944565 |
| 127 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.44742277 |
| 128 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.43622673 |
| 129 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.43535714 |
| 130 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.42782958 |
| 131 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.41478824 |
| 132 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.40698828 |
| 133 | Long-term depression_Homo sapiens_hsa04730 | 0.38573986 |
| 134 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.38297557 |
| 135 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.37906064 |
| 136 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.37460038 |
| 137 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37288249 |
| 138 | Adherens junction_Homo sapiens_hsa04520 | 0.36937897 |
| 139 | Platelet activation_Homo sapiens_hsa04611 | 0.36303033 |
| 140 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.34150233 |
| 141 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.26898206 |
| 142 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.23868516 |
| 143 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.23590788 |
| 144 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.21692903 |
| 145 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.21205001 |
| 146 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.13113526 |
| 147 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.09281910 |
| 148 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.08895743 |
| 149 | Insulin resistance_Homo sapiens_hsa04931 | 0.07941215 |
| 150 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.04750758 |

